Skip to main content

4 Result(s)

within Keith Tankel Remove this filter

and

  1. No Access

    Article

    Effects of exercise during and after neoadjuvant chemoradiation on symptom burden and quality of life in rectal cancer patients: a phase II randomized controlled trial

    We previously demonstrated that exercise during and after neoadjuvant chemoradiation (NACRT) for rectal cancer may improve the rate of pathologic complete/near complete response. Here, we report the effects of...

    Andria R. Morielli, Normand G. Boulé, Nawaid Usmani… in Journal of Cancer Survivorship (2023)

  2. Article

    Open Access

    Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial

    Standard treatment for locally advanced rectal cancer includes 5–6 weeks of neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal excision 6–8 weeks later. NACRT improves local disease control and...

    Andria R. Morielli, Nawaid Usmani, Normand G. Boulé, Diane Severin, Keith Tankel… in Trials (2018)

    Download PDF (818 KB) View Article

  3. No Access

    Article

    Exercise motivation in rectal cancer patients during and after neoadjuvant chemoradiotherapy

    Aerobic exercise is safe and feasible for rectal cancer patients during and after neoadjuvant chemoradiotherapy (NACRT), but their motivation to perform such exercise is unknown. Here, we explore the motivatio...

    Andria R. Morielli, Nawaid Usmani, Normand G. Boulé… in Supportive Care in Cancer (2016)

  4. No Access

    Article

    Atypical reversible posterior leukoencephalopathy syndrome (RPLS) induced by cediranib in a patient with metastatic rectal cancer

    Background Reversible posterior leukoenecphalopathy syndrome (RPLS) is a rare clinicoradiologic syndrome characterized by neurologic symptoms such as seizures, headaches, visual abnormali...

    Christina A. K. Kim, Julie Price-Hiller, Quincy S. Chu… in Investigational New Drugs (2014)